At a glance Direct interaction data / none published in human trials as of May 2026 BPC-157 primary mechanism / nitric oxide system modulation, angiogenesis, and GI cytoprotection Ashwagandha primary mechanism / HPA-axis modulation, cortisol reduction, withanolide-driven adaptogenesis Overlap concern / both influence the hypothalamic-pituitary-adrenal and hypothalamic-pituitary-thyroid axes Suggested dose separation / 30 to 60 minutes between oral ashwagandha and oral BPC-157 Monitoring labs / TSH, free T4, morning cortisol at baseline and every 8 to 12 weeks Ashwagandha cortisol reduction / 30.5% decrease in serum cortisol vs
PD is characterized by loss of dopaminergic neurons in the substantia nigra pars compacta and the presence of aggregated, intracellular inclusions containing -synuclein, termed Lewy bodies [199]
References: Gwyer, D., Wragg, N
10.1016/j.neuron.2006.05.008 111 WeimerR
Key scientific figures and citations Cagrilintide is a long-acting amylin analogue that, when combined with semaglutide, produced clinically meaningful and dose-dependent weight loss in adults with overweight or obesity. Enebo LB